Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel with Chemoradiotherapy in Squamous-cell Anal Cancer
NCT02526953Phase 3Unknown
- Sponsor
- N.N. Blokhin Russian Cancer Research Center
- Start
- Jan 2016
- Primary completion
- Oct 2021
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection in Squamous Cell Anal Cancer (SCAC), sponsored by N.N. Blokhin Russian Cancer Research Center. Status: unknown.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
Squamous Cell Anal Cancer (SCAC)
Beyond the preview
Go deeper on NCT02526953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02526953.